抗Jo-1抗体在特发性炎性肌病临床分层及疾病谱中的意义
|
|
李嘉辰,赖展鸿,邵苗,金月波,高小娟,张科,侯儆,张燕英,栗占国,李玉慧
|
Significance of anti-Jo-1 antibody's clinical stratification in idiopathic inflammatory myopathy and disease spectrum
|
|
Jia-chen LI,Zhan-hong LAI,Miao SHAO,Yue-bo JIN,Xiao-juan GAO,Ke ZHANG,Jing HOU,Yan-ying ZHANG,Zhan-guo LI,Yu-hui LI
|
|
表2 抗Jo-1抗体滴度与ASS患者临床特征及实验室数据的相关性分析
|
Table 2 Correlation analysis between anti-Jo-1 antibody titer and clinical features and laboratory data of ASS patients
|
|
| Items | Anti-Jo-1 (+) (n=15) | Anti-Jo-1 (++) (n=15) | Anti-Jo-1 (+++)(n=54) | r | P | | Clinical features | | | | | | | Fever | 5 (33.3) | 4 (26.7) | 9 (16.7) | -0.163 | 0.140 | | ILD | 12 (80.0) | 13 (86.7) | 47 (87.0) | 0.062 | 0.576 | | Arthritis | 4 (26.7) | 7 (46.7) | 40 (74.1) | 0.385 | < 0.001 | | Myalgia | 6 (40.0) | 11 (73.3) | 24 (44.4) | -0.071 | 0.521 | | Myasthenia | 6 (40.0) | 8 (53.3) | 32 (59.3) | 0.136 | 0.218 | | Dysphagia | 0 | 0 | 5 (9.3) | 0.183 | 0.096 | | Mechanic hands | 4 (26.7) | 8 (53.3) | 33 (61.1) | 0.233 | 0.033 | | Raynaud phenomenon | 0 | 1 (2.6) | 10 (15.2) | 0.223 | 0.041 | | Gottron sign | 9 (60.0) | 12 (80.0) | 47 (87.3) | 0.236 | 0.031 | | Malignancy | 1 (6.7) | 0 | 1 (1.9) | -0.074 | 0.504 | | Neurologic abnormality | 1 (6.7) | 0 | 3 (5.6) | 0.028 | 0.797 | | Laboratory data | | | | | | | Elevated WBC | 7 (46.7) | 10 (66.7) | 38 (70.4) | 0.162 | 0.141 | | Decreased lymphocyte | 8 (53.3) | 9 (60.0) | 31 (57.4) | 0.016 | 0.887 | | Elevated neutrophil | 10 (66.7) | 11 (73.3) | 38 (70.4) | 0.013 | 0.905 | | Elevated ESR | 7 (46.7) | 4 (26.7) | 31 (57.4) | 0.159 | 0.151 | | Elevated CRP | 7 (46.7) | 1 (6.7) | 24 (44.4) | 0.087 | 0.445 | | Decreased albumin | 13 (86.7) | 10 (66.7) | 40 (74.1) | -0.058 | 0.600 | | Elevated CK | 4 (26.7) | 8 (53.3) | 34 (63.0) | 0.263 | 0.016 | | Elevated LDH | 13 (86.7) | 10 (66.7) | 43 (79.6) | 0.002 | 0.958 | | Elevated α-HBD | 10 (66.7) | 9 (60.0) | 47 (87.0) | 0.255 | 0.021 |
|
|
|